Study finds new molecular pathways involved with autoimmune diseases, potential implications for therapies

September 28, 2012
Study finds new molecular pathways involved with autoimmune diseases, potential implications for therapies
Different arrangement of the IRF-4 (blue)/BATF-JunB (red) complex in different promoter sites leads to the activation of the Ctla-4 receptor and Bcl11b gene expression respectively. Credit: Carlos Escalante, Ph.D./VCU

Teamwork between a pair of transcription factors may be responsible for regulating the functioning of Th17 cells, which when found in excessive amounts are believed to play a major role in many autoimmune diseases, according to a study published last week in the journal Science by a national team of researchers.

The findings may help researchers develop potential therapies against autoimmune disease such as multiple sclerosis, psoriasis, , rheumatoid arthritis and .

The collaborative study was led by researchers at Genetech, Inc., in San Francisco, and included researchers from the Virginia Commonwealth University School of Medicine, the Howard Hughes Medical Institute in Chevy Chase, Md., the Washington University School of Medicine in St. Louis, the University of Chicago, New York University and the M.D. Anderson Cancer Center in Houston.

The team reported on new composite DNA sites that included binding sites for both IRF4 and BATF. The composite sites had variations in the spacing separating the two individual sites leading to different arrangement of the two . Transcription factors serve as traffic coordinators, controlling the flow of genetic information from DNA to mRNA.

The study shows that this different arrangement leads to the activation of different genes. Activation of several genes during differentiation of Th17 cells is promoted by the partnership of IRF4 and BATF.

"The work shows for the first time that the transcription factors IRF4 and BATF through cooperative binding to composite DNA sites are critical for the differentiation of T helper 17 cells," said study contributor Carlos R. Escalante, Ph.D., assistant professor in the Department of Physiology and Biophysics in the VCU School of Medicine. Escalante was involved in the generation of the atomic models of the different IRF4-BATF-DNA complexes.

Explore further: Mouse pancreatic stem cells successfully differentiate into insulin producing cells

Related Stories

Mouse pancreatic stem cells successfully differentiate into insulin producing cells

September 25, 2012
In a study to investigate how transplanted islet cells can differentiate and mature into insulin-producing pancreatic cells, a team of Japanese researchers found that using a specific set of transcription factors (proteins ...

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.